Stock listing
BIOCON Stock Price, News, Filings & Events — Biocon Limited
Selected listing: BIOCON · BSE · INR · IN
BIOCON:BSE is a public company based in India with a market capitalization of approximately $7.27 billion. The company specializes in biopharmaceuticals, providing a diverse portfolio of products targeting diabetes, oncology, and autoimmune diseases. Biocon is dedicated to innovation and aims to enhance access to affordable healthcare solutions. Recent developments and filings reflect the company's ongoing commitment to advancing its product offerings and market presence.
- Ticker
- BIOCON:BSE
- Asset type
- Stock
- Market cap
- $7.27B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BSE
- Currency
- INR
Biocon Limited BIOCON:BSE stock context
BIOCON:BSE is a public company based in India with a market capitalization of approximately $7.27 billion. The company specializes in biopharmaceuticals, providing a diverse portfolio of products targeting diabetes, oncology, and autoimmune diseases. Biocon is dedicated to innovation and aims to enhance access to affordable healthcare solutions. Recent developments and filings reflect the company's ongoing commitment to advancing its product offerings and market presence.
Research Biocon Limited
Biocon Limited investor report
Review AI stock analysis and investor report context for BIOCON:BSE.
Biocon Limited company profile
View the public company page for Biocon Limited on 6ix.
Biocon Limited news
Read company news and market updates connected to Biocon Limited.
Biocon Limited investor events
Find investor webinars, events, and replay context for Biocon Limited.